Details for Patent: 8,987,441
✉ Email this page to a colleague
Which drugs does patent 8,987,441 protect, and when does it expire?
Patent 8,987,441 protects XOFLUZA and is included in two NDAs.
This patent has thirty-two patent family members in twenty-three countries.
Summary for Patent: 8,987,441
| Title: | Substituted polycyclic carbamoyl pyridone derivative prodrug |
| Abstract: | The present invention provides a compound having antiviral effects, particularly having growth inhibitory activity on influenza viruses, a preferred example of the compound being a substituted 3-hydroxy-4-pyridone derivative prodrug having cap-dependent endonuclease inhibitory activity. |
| Inventor(s): | Takahashi; Chika (Toyonaka, JP), Mikamiyama; Hidenori (Toyonaka, JP), Akiyama; Toshiyuki (Toyonaka, JP), Tomita; Kenji (Toyonaka, JP), Taoda; Yoshiyuki (Toyonaka, JP), Kawai; Makoto (Toyonaka, JP), Anan; Kosuke (Toyonaka, JP), Miyagawa; Masayoshi (Toyonaka, JP), Suzuki; Naoyuki (Toyonaka, JP) |
| Assignee: | Shionogi & Co., Ltd. (Osaka, JP) |
| Application Number: | 13/824,723 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; |
Drugs Protected by US Patent 8,987,441
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genentech Inc | XOFLUZA | baloxavir marboxil | FOR SUSPENSION;ORAL | 214410-001 | Nov 23, 2020 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
| Genentech Inc | XOFLUZA | baloxavir marboxil | TABLET;ORAL | 210854-001 | Oct 24, 2018 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
| Genentech Inc | XOFLUZA | baloxavir marboxil | TABLET;ORAL | 210854-002 | Oct 24, 2018 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
| Genentech Inc | XOFLUZA | baloxavir marboxil | TABLET;ORAL | 210854-003 | Mar 18, 2021 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,987,441
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Japan | 2010-213012 | Sep 24, 2010 |
| PCT Information | |||
| PCT Filed | September 21, 2011 | PCT Application Number: | PCT/JP2011/071446 |
| PCT Publication Date: | March 29, 2012 | PCT Publication Number: | WO2012/039414 |
International Family Members for US Patent 8,987,441
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2620436 | ⤷ Sign Up | C02620436/01 | Switzerland | ⤷ Sign Up |
| European Patent Office | 2620436 | ⤷ Sign Up | 301093 | Netherlands | ⤷ Sign Up |
| European Patent Office | 2620436 | ⤷ Sign Up | PA2021505 | Lithuania | ⤷ Sign Up |
| European Patent Office | 2620436 | ⤷ Sign Up | 122021000017 | Germany | ⤷ Sign Up |
| European Patent Office | 2620436 | ⤷ Sign Up | CA 2021 00004 | Denmark | ⤷ Sign Up |
| European Patent Office | 2620436 | ⤷ Sign Up | 2021C/510 | Belgium | ⤷ Sign Up |
| European Patent Office | 2620436 | ⤷ Sign Up | 132021000000038 | Italy | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
